PROCYTE CORP /WA/
10-Q, EX-27, 2000-07-31
PHARMACEUTICAL PREPARATIONS
Previous: PROCYTE CORP /WA/, 10-Q, 2000-07-31
Next: KAISER GROUP INTERNATIONAL INC, 8-K, 2000-07-31



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                       3,078,635
<SECURITIES>                                         0
<RECEIVABLES>                                  906,500
<ALLOWANCES>                                  (65,421)
<INVENTORY>                                    781,464
<CURRENT-ASSETS>                             4,937,342
<PP&E>                                       6,139,336
<DEPRECIATION>                             (3,589,336)
<TOTAL-ASSETS>                              12,402,094
<CURRENT-LIABILITIES>                          480,152
<BONDS>                                              0
                                0
                                          0
<COMMON>                                    85,084,167
<OTHER-SE>                                (73,162,225)
<TOTAL-LIABILITY-AND-EQUITY>                12,402,094
<SALES>                                      2,339,546
<TOTAL-REVENUES>                             3,150,728
<CGS>                                          629,568
<TOTAL-COSTS>                                3,684,388
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (1,060,833)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,060,833)
<EPS-BASIC>                                     (0.07)
<EPS-DILUTED>                                   (0.07)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission